These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Ocular Surface Squamous Neoplasia Following Keratoplasty in Xeroderma Pigmentosa: A Series of Seven Cases. Vempuluru VS; Ganguly A; Kaliki S Curr Eye Res; 2021 Nov; 46(11):1631-1636. PubMed ID: 33908328 [No Abstract] [Full Text] [Related]
6. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications. Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578 [TBL] [Abstract][Full Text] [Related]
7. Ocular surface squamous neoplasia as the initial presenting sign of human immunodeficiency virus infection in 60 Asian Indian patients. Kaliki S; Kamal S; Fatima S Int Ophthalmol; 2017 Oct; 37(5):1221-1228. PubMed ID: 27826936 [TBL] [Abstract][Full Text] [Related]
8. Ocular surface squamous neoplasia at a tertiary eye facility, Southwestern Nigeria: a 10-year review. Fasina O Int Ophthalmol; 2021 Oct; 41(10):3325-3331. PubMed ID: 34014459 [TBL] [Abstract][Full Text] [Related]
9. Ocular Surface Squamous Neoplasia in 200 Patients: A Case-Control Study of Immunosuppression Resulting from Human Immunodeficiency Virus versus Immunocompetency. Kamal S; Kaliki S; Mishra DK; Batra J; Naik MN Ophthalmology; 2015 Aug; 122(8):1688-94. PubMed ID: 26050538 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic correlation of ocular surface squamous neoplasia from a university hospital in North Taiwan 1994 to 2014. Ma IH; Hu FR; Wang IJ; Chen WL; Hsu YJ; Chu HS; Yuan CT; Hou YC J Formos Med Assoc; 2019 Apr; 118(4):776-782. PubMed ID: 30266199 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population. Kim BH; Kim MK; Wee WR; Oh JY Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080 [TBL] [Abstract][Full Text] [Related]
12. Ocular and Periocular Tumors in Xeroderma Pigmentosum: A Study of 120 Asian Indian Patients. Kaliki S; Jajapuram SD; Maniar A; Mishra DK Am J Ophthalmol; 2019 Feb; 198():146-153. PubMed ID: 30336128 [TBL] [Abstract][Full Text] [Related]
14. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study. Blasi MA; Maceroni M; Sammarco MG; Pagliara MM Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069 [TBL] [Abstract][Full Text] [Related]
15. Ocular surface squamous neoplasia: management and outcomes. Hӧllhumer R; Williams S; Michelow P Eye (Lond); 2021 Jun; 35(6):1562-1573. PubMed ID: 33564137 [TBL] [Abstract][Full Text] [Related]
17. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment. Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390 [TBL] [Abstract][Full Text] [Related]
18. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction. Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315 [TBL] [Abstract][Full Text] [Related]
19. Predictors of Ocular Surface Squamous Neoplasia and Conjunctival Squamous Cell Carcinoma among Ugandan Patients: A Hospital-based Study. Lloyd HCM; Arunga S; Twinamasiko A; Frederick MA; Onyango J Middle East Afr J Ophthalmol; 2018; 25(3-4):150-155. PubMed ID: 30765953 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical 5-Fluorouracil in the management of ocular surface squamous neoplasia: a study of 101 eyes. Bakal K; Molugu S; Machakuri K; Bejjanki KM; Kapoor AG; Kaliki S Int Ophthalmol; 2024 Jun; 44(1):251. PubMed ID: 38907750 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]